Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

The 2024 Sex Lives Report by LetsStopAIDS found 34% of youth diagnosed with an STI or HIV did not receive treatment — an ...

Less than half of those who tested positive for HIV in Pretoria were aware of their HIV status. As such they would not have ...

People with HIV can safely receive donated kidneys from deceased donors with the virus, according to a large study that comes ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

Researchers conducted a cross-sectional analysis to evaluate bone health among menopausal women in Zimbabwe with and without human immunodeficiency virus.

On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...

Gilead Sciences and Merck presented Phase 2 results showing 94.2% viral suppression in HIV patients treated with islatravir and lenacapavir. Both weekly and daily treatments achieved comparable ...

Doctors and front-line workers are watching closely as HIV rates increase significantly in Alberta.An annual Alberta Health ...

Cancer, malaria and pneumonia continue to be some of Kenya’s biggest health challenges despite the scale-up of intervention tools, and that is expected to be the case in coming years.

An analysis by Li Tao, MD, MS, PhD, director of real-world evidence at Gilead Sciences, and colleagues looked at statistical ...

The national HIV prevalence was 16.3% among adults aged 15 years and older, translating to an estimated 7.4 million adults ...